Other Updated 2022-02-03

BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion

Recalled Product

BEOVU (brolucizumab)


Hazard / Issue

New safety information - Product safety

Issued by

Marketed health products

View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon Canada →